deTACE的临床优势，DCB竞争策略和对比分析.pptx

DeTACE临床优势内容deTACE介绍HepaSpherePROVISION V对deTACE的质疑有效性安全性deTACE的获益HepaSphere与DC Bead比较参数对比竞争性分析及策略经肝动脉化疗栓塞术（TACE）的带药形式化疗药物，碘油乳剂或颗粒栓塞剂TACE等不同给药方式的药物分布系统化疗cTACEdeTACE载多柔比星栓塞剂多柔比星 + 碘油栓塞剂经静脉注射多柔比星Lee et al. “Doxorubicin-Loaded QuadraSphere Microspheres: Plasma Pharmacokinetics and Intratumoral Drug Concentration in an Animal Model of Liver Cancer.” Cardiovasc Intervent Radiol 2010; 33(3): 576–82.van Malenstein H et al. “A Randomized Phase II Study of Drug-Eluting Beads versus Transarterial Chemoembolization for Unresectable Hapetocellular Carcinoma.” Onkologie 2011;34:368-76.Malagari et al 2014.